Keenova
Highly Engaged Employees
Manufacturing · Ireland · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
College Business & Technology Park Cruis...Phone Number
+353 16960000Website
www.keenova.comRevenue
$540.1 MillionIndustry
About Keenova
Keenova Org Chart
Is Keenova your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Keenova
Check if Keenova has recently received funding, and reach out quickly before it becomes old news!
Keenova, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Keenova launches new products
Funding: Get notified immidiatlly once Keenova has new funding data
Click to see if Keenova had a recent Job posting/layoffs
Check out if Keenova is spiking on competitors!
Earning: See what the market has to say on Keenova recently announced quarterly report
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Keenova
Find 3 more new buyers
Company Profile Activity
Activity Insights
Keenova is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Keenova is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Keenova.
Keenova Tech Stack
A closer look at the technologies used by Keenova
Keenova News & Media
Keenova Announces Newly Updated Peyronie's Disease Study Results at American Urology Association Meeting
DUBLIN, May 15, 2026 /PRNewswire/ -- Keenova Therapeutics plc announced today that new and final updated data from its dedicated ventral curvature analysis of Peyronie's disease and XIAFLEX® (collagenase clostridium histolyticum) will be shared at the American Urological Association (AUA)...Keenova Reports First Quarter 2026 Financial Results
Strong First-Quarter Performance Driven by Acthar® Gel1 and XIAFLEX®2 Pipeline Development, Synergy Plan Remain on Track Reaffirms 2026 Net Sales Guidance of $1.94 Billion to $2.00 Billion and Adjusted EBITDA Guidance of $730 Million to $760 Million Conference Call and Webcast Today at...Keenova Launches New Consumer Campaign for Dupuytren's Contracture: Don't Be a Viking
Dupuytren's contracture, a.k.a. Viking Hand, is a progressive hand condition affecting an estimated 13 million Americans DUBLIN, May 4, 2026 /PRNewswire/ -- Keenova Therapeutics plc announced today the launch of its newest television commercial and disease awareness campaign, Don't Be a...Keenova Presents a New TERLIVAZ® (terlipressin) Clinical Analysis at Digestive Disease Week
DUBLIN, May 1, 2026 /PRNewswire/ -- Keenova Therapeutics plc announced today that a new presentation on hepatorenal syndrome-acute kidney injury (HRS‑AKI) and TERLIVAZ® (terlipressin) will be shared at Digestive Disease Week (DDW), taking place May 2-5, 2026. "We are pleased to share...
Top Manufacturing Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Keenova
Based in Dublin, Ireland, Keenova (formerly Mallinckrodt Pharmaceuticals) is a therapeutics company focused on targeted, specialty treatments. It addresses gaps in patient care by delivering science-based medicines and working with payors and providers to ensure patients access the therapies they need.... Read More